Robert W. Schrier

Tolvaptan, a Selective Oral Vasopressin V ₂ -Receptor Antagonist, for Hyponatremia

Robert W. Schrier, Mihai Gheorghiade, Tomás Berl et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

Raymond O. Estacio, Barrett W. Jeffers, William R. Hiatt et al. · New England Journal of Medicine · 1998 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations

Joseph G. Verbalis, Steven R. Goldsmith, Arthur Greenberg et al. · The American Journal of Medicine · 2013 · 1.2K citations

Medicine, Internal Medicine, Nephrology +8

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

Robert W. Schrier, Raymond O. Estacio, Anne Esler et al. · Kidney International · 2002 · 850 citations · Full text

Medicine, Endocrinology, Internal Medicine +14

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Raymond O. Estacio, Barrett W. Jeffers, Nancy Gifford et al. · PubMed · 2000 · 696 citations

Medicine, Pharmacology, Pharmacotherapy +17